ST. PAUL, Minn.--(BUSINESS WIRE)-- FIRST QUARTER HIGHLIGHTS:

• Reported sales $3.6 billion, +9% versus last year. Organic sales +13%, led by double-digit growth in the Institutional & Specialty, Industrial, and Other segment, and improved growth in the Healthcare & Life Sciences segment.
• Reported operating income +38%. Organic operating income growth accelerated to +19%, as continued strong pricing and productivity gains more than offset easing but ongoing delivered product cost inflation and challenging macroeconomic conditions.
• Reported operating income margin 9.8%. Organic operating income margin 10.6%, +50 bps versus last year, reflecting modest gross margin expansion and improved productivity.
• Reported diluted EPS $0.82, +37%. Adjusted diluted EPS, excluding special gains and charges and discrete tax items were $0.88, +7%. Currency translation and higher interest expense had a combined $0.11 per share unfavorable impact on first quarter EPS.

2023 OUTLOOK

• 2023: Ecolab continues to expect to deliver quarterly adjusted earnings per share growth that accelerates towards its low double-digit historical performance.
• 2Q 2023: Expect second quarter 2023 adjusted diluted earnings per share in the $1.15 to $1.25 range, +5 to 14% versus last year.

	First Quarter Ended March 31
	Reported											Adjusted
(unaudited)	Public Currency Rates								%			Public Currency Rates								%
(millions, except per share)	2023				2022				Change				2023			2022				Change
Net sales	$	3,571.6			$	3,266.7			9	%		$	3,571.6			$	3,266.7			9	%
Operating income		351.6				254.5			38	%			379.3				331.5			14	%
Net income attributable to Ecolab		233.4				171.9			36	%			250.5				236.5			6	%
Diluted earnings per share attributable to Ecolab	$	0.82			$	0.60			37	%		$	0.88			$	0.82			7	%
	Organic								%
	2023				2022				Change
Net sales	$	3,533.8			$	3,137.7			13	%
Operating income		376.1				315.5			19	%

CEO Comment

Christophe Beck, Ecolab’s chairman and chief executive officer, said, “We had a very strong start to 2023 with our team delivering continued double-digit organic sales growth, consistent with our expectations. We continued taking steps to further strengthen our growth foundation, like making investments in our Life Sciences business to capitalize on its long-term growth opportunities. Overall, our efforts drove organic operating income margin expansion with continued strong pricing and further productivity gains, in addition to easing but ongoing inflationary headwinds. This excellent performance resulted in 19% growth in organic operating income and accelerating growth in adjusted earnings per share despite significant currency translation and interest expense headwinds in a challenging macroeconomic environment.

“Looking ahead, we are well positioned to build on our operating momentum and expect further performance improvement in 2023. While the macroeconomic headwinds and inflationary pressures are expected to persist, our focus remains on offense – driving robust sales growth as we leverage our leading customer value proposition and our innovation pipeline, as well as on capturing our significant operating margin expansion opportunity. As a result, we continue to anticipate strong organic sales gains, double-digit growth in organic operating income, and adjusted earnings per share growth that accelerates towards our low double-digit historical performance.”

First Quarter 2023 Consolidated Results

Ecolab’s first quarter reported sales increased 9% and organic sales increased 13% when compared to the prior year.

First quarter 2023 reported operating income increased 38% and includes the impact of special gains and charges, which were a net charge primarily related to restructuring costs. Organic operating income growth accelerated to 19%, as strong pricing overcame investments in the business, higher delivered product costs, and softer volume.

Reported other income decreased $6 million in the first quarter of 2023 due to higher pension costs.

Reported interest expense increased 40% reflecting the impact from higher average interest rates on floating rate debt and last year’s fourth quarter debt issuance.

The reported income tax rate for the first quarter of 2023 was 18.0% compared with the reported rate of 20.7% in the first quarter of 2022. Excluding special gains and charges and discrete tax items, the adjusted tax rate for the first quarter of 2023 was 19.8% compared with the adjusted tax rate of 19.5% in the first quarter of 2022.

Reported net income increased 36% versus the prior year. Excluding the impact of special gains and charges and discrete tax items, adjusted net income increased 6% versus the prior year.

Reported diluted earnings per share increased 37% versus the prior year. Adjusted diluted earnings per share increased 7% when compared against the first quarter of 2022. Currency translation had a $0.05 unfavorable impact on first quarter 2023 earnings per share.

First Quarter 2023 Segment Review

Global Industrial
(unaudited)	First Quarter Ended March 31											Organic
(millions)	2023				2022				% Change			% Change
Fixed currency
Sales	$	1,699.3			$	1,511.4			12	%		12	%
Operating income		215.6				179.9			20	%		20	%
Operating income margin		12.7	%			11.9	%
Organic operating income margin		12.7	%			11.9	%
Public currency
Sales	$	1,709.4			$	1,565.7			9	%
Operating income		217.7				191.1			14	%

The Industrial segment includes Water, Food & Beverage, and Paper

Effective January 1, 2023, the Company’s former Downstream operating segment is now part of the Water operating segment.  This change did not have any impact on the Global Industrial reportable segment.

Global Institutional & Specialty
(unaudited)	First Quarter Ended March 31											Organic
(millions)	2023				2022				% Change			% Change
Fixed currency
Sales	$	1,126.6			$	991.3			14	%		14	%
Operating income		125.7				108.6			16	%		16	%
Operating income margin		11.2	%			11.0	%
Organic operating income margin		11.2	%			11.0	%
Public currency
Sales	$	1,128.8			$	1,009.4			12	%
Operating income		125.9				110.9			14	%

The Institutional & Specialty segment includes Institutional and Specialty

Organic sales growth accelerated to 14%. Continued double-digit growth in the Institutional division reflected strong pricing and new business wins. Specialty sales growth accelerated, driven by robust quickservice sales growth. Organic operating income growth accelerated to 16% as strong pricing overcame investments in the business, higher delivered product costs, and unfavorable mix.

Global Healthcare & Life Sciences
(unaudited)		First Quarter Ended March 31											Organic
(millions)		2023				2022				% Change			% Change
Fixed currency
Sales		$	378.6			$	348.2			9	%		9	%
Operating income			35.0				41.9			(16	)%		(16	)%
Operating income margin			9.2	%			12.0	%
Organic operating income margin			9.2	%			12.0	%
Public currency
Sales		$	379.7			$	362.8			5	%
Operating income			35.2				44.3			(21	)%

The Healthcare & Life Sciences segment includes Healthcare and Life Sciences

Organic sales grew 9%, driven by double-digit growth in Life Sciences and strengthening Healthcare sales growth. Organic operating income decreased 16%, as strong pricing was more than offset by softer volume, targeted investments in the business, and higher delivered product costs.

Other
(unaudited)	First Quarter Ended March 31											Organic
(millions)	2023				2022				% Change			% Change
Fixed currency
Sales	$	329.3			$	286.8			15	%		15	%
Operating income		50.1				37.1			35	%		35	%
Operating income margin		15.2	%			12.9	%
Organic operating income margin		15.2	%			12.9	%
Public currency
Sales	$	330.0			$	294.0			12	%
Operating income		50.2				37.9			32	%

The Other segment includes Pest Elimination, Textile Care and Colloidal Technologies

Organic sales growth accelerated to 15%, reflecting double-digit growth across all divisions, with continued strong performance in Pest Elimination. Organic operating income increased 35% as strong pricing overcame investments in the business, higher delivered product costs, and unfavorable mix.

Corporate
(unaudited)		First Quarter Ended March 31
(millions)		2023					2022
Public currency
Sales		$	23.7				$	34.8
Corporate operating expense
Nalco and Purolite amortization			50.2					52.7
Special (gains) and charges			27.7					77.0
Other			(0.5	)				-
Total Corporate operating expense		$	77.4				$	129.7

First quarter of 2023 corporate segment includes:

• sales of $24 million to ChampionX under the Master Cross Supply and Product Transfer agreements Ecolab entered into as part of the ChampionX separation
• amortization expense of $29 million related to the Nalco merger intangible assets and $21 million related to Purolite acquisition intangible assets
• special gains and charges were a net charge of $28 million, primarily related to restructuring costs

Special gains and charges for the first quarter of 2022 were a net charge of $77 million and primarily reflected Purolite acquisition costs, COVID-related charges, and charges related to our operations in Russia.

Business Outlook

2023

Ecolab continues to expect to deliver performance that improves despite a challenging macro environment characterized by high delivered product costs and easing demand. In addition, higher interest expense and currency translation are estimated to have a combined $0.30 per share unfavorable impact in 2023, or a 7% headwind to year-over-year earnings growth.

The Company expects double-digit growth in organic operating income, driven by continued robust sales growth, easing delivered product cost inflation, and improved productivity. This strong performance is expected to more than overcome the challenging environment to deliver quarterly adjusted earnings per share growth that accelerates towards our low double-digit historical performance.

2023 – Second Quarter

Ecolab expects second quarter 2023 adjusted diluted earnings per share in the $1.15 to $1.25 range, compared with adjusted diluted earnings per share of $1.10 a year ago. This forecast includes an estimated unfavorable $0.12 per share impact from higher interest expense and currency translation, or a 11% headwind to year-over-year earnings growth.

The Company currently expects quantifiable special charges in the second quarter of 2023 to be approximately $0.08 per share, principally related to restructuring charges. Other than the special gains and charges noted above, other such amounts are not currently quantifiable.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on a century of innovation, Ecolab has annual sales of $14 billion, employs more than 47,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, life sciences, hospitality and industrial markets. www.ecolab.com

Ecolab will host a live webcast to review the first quarter earnings announcement today at 1:00 p.m. Eastern Time. The webcast, along with related materials, will be available to the public on Ecolab's website at www.ecolab.com/investor. A replay of the webcast and related materials will be available at that site.

Cautionary Statements Regarding Forward-Looking Information

This news release contains certain statements relating to future events and our intentions, beliefs, expectations and predictions for the future which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project,” “may,” “will,” “intend,” “plan,” “believe,” “target,” “forecast” (including the negative or variations thereof) or similar terminology used in connection with any discussion of future plans, actions or events generally identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding macroeconomic conditions, delivered product costs, demand, inflation, currency translation, and our financial and business performance and prospects, including sales, earnings, special charges, margins, interest expense, and productivity. These statements are based on the current expectations of management of the company. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this news release. In particular, the ultimate results of any restructuring initiative depend on a number of factors, including the development of final plans, the impact of local regulatory requirements regarding employee terminations, the time necessary to develop and implement the restructuring initiatives and the level of success achieved through such actions in improving competitiveness, efficiency and effectiveness.

Additional risks and uncertainties that may affect operating results and business performance are set forth under Item 1A of our most recent Form 10-K, and our other public filings with the Securities and Exchange Commission (the "SEC"), and include the impact of economic factors such as the worldwide economy, capital flows, interest rates, foreign currency risk, reduced sales and earnings in our international operations resulting from the weakening of local currencies versus the U.S. dollar, demand uncertainty, supply chain challenges and inflation; the vitality of the markets we serve; exposure to global economic, political and legal risks related to our international operations, including geopolitical instability, the impact of sanctions or other actions taken by the U.S. or other countries, and retaliatory measures taken by Russia in response, in connection with the conflict in Ukraine; difficulty in procuring raw materials or fluctuations in raw material costs; our ability to attract, retain and develop high caliber management talent to lead our business and successfully execute organizational change and changing labor market dynamics; information technology infrastructure failures or breaches in data security; the effects and duration of the COVID-19 pandemic or other public health outbreaks, epidemics or pandemics; our ability to acquire complementary businesses and to effectively integrate such businesses, including Purolite; our ability to execute key business initiatives, including restructurings and our Enterprise Resource Planning system upgrades; our ability to successfully compete with respect to value, innovation and customer support; pressure on operations from consolidation of customers or vendors; restraints on pricing flexibility due to contractual obligations and our ability to meet our contractual commitments; the costs and effects of complying with laws and regulations, including those relating to the environment, climate change standards, and to the manufacture, storage, distribution, sale and use of our products, as well as to the conduct of our business generally, including labor and employment and anti-corruption; potential chemical spill or release; our commitments, goals, targets, objectives and initiatives related to sustainability; potential to incur significant tax liabilities or indemnification liabilities relating to the separation and split-off of our ChampionX business; the occurrence of litigation or claims, including class action lawsuits; the loss or insolvency of a major customer or distributor; repeated or prolonged government and/or business shutdowns or similar events; acts of war or terrorism; natural or man-made disasters; water shortages; severe weather conditions; changes in tax laws and unanticipated tax liabilities; potential loss of deferred tax assets; our indebtedness, and any failure to comply with covenants that apply to our indebtedness; potential losses arising from the impairment of goodwill or other assets; and other uncertainties or risks reported from time to time in our reports to the SEC. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed in this news release may not occur. We caution that undue reliance should not be placed on forward-looking statements, which speak only as of the date made. Ecolab does not undertake, and expressly disclaims, any duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations, except as required by law.

Non-GAAP Financial Information

This news release and certain of the accompanying tables include financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

These non-GAAP financial measures include:

• fixed currency sales
• organic sales, formerly known as acquisition adjusted fixed currency sales
• adjusted cost of sales
• adjusted gross profit
• adjusted gross margin
• fixed currency operating income
• adjusted operating income
• adjusted fixed currency operating income
• adjusted fixed currency operating income margin
• organic operating income, formerly known as acquisition adjusted fixed currency operating income
• organic operating income margin, formerly known as acquisition adjusted fixed currency operating income margin
• adjusted tax rate
• adjusted net income attributable to Ecolab
• adjusted diluted earnings per share

We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.

Our non-GAAP financial measures for adjusted cost of sales, adjusted gross margin, adjusted gross profit and adjusted operating income exclude the impact of special (gains) and charges and our non-GAAP financial measures for adjusted tax rate, adjusted net income attributable to Ecolab and adjusted diluted earnings per share further exclude the impact of discrete tax items. We include items within special (gains) and charges and discrete tax items that we believe can significantly affect the period-over-period assessment of operating results and not necessarily reflect costs and/or income associated with historical trends and future results. After tax special (gains) and charges are derived by applying the applicable local jurisdictional tax rate to the corresponding pre-tax special (gains) and charges.

We evaluate the performance of our international operations based on fixed currency rates of foreign exchange, which eliminate the translation impact of exchange rate fluctuations on our international results. Fixed currency amounts included in this release are based on translation into U.S. dollars at the fixed foreign currency exchange rates established by management at the beginning of 2023. We also provide our segment results based on public currency rates for informational purposes.

Our reportable segments do not include the impact of intangible asset amortization from the Nalco and Purolite transactions or the impact of special (gains) and charges as these are not allocated to the Company’s reportable segments.

Our non-GAAP financial measures for organic sales, organic operating income and organic operating income margin are at fixed currency and exclude the impact of special (gains) and charges, the results of our acquired businesses from the first twelve months post acquisition and the results of divested businesses from the twelve months prior to divestiture. In addition, as part of the separation, we also entered into a Master Cross Supply and Product Transfer agreement with ChampionX to provide, receive or transfer certain products for a period up to 36 months and for a small set of products with limited suppliers over the next few years. Sales of product to ChampionX under this agreement are recorded in product and equipment sales in the Corporate segment along with the related cost of sales. These transactions are removed from the consolidated results as part of the calculation of the impact of acquisitions and divestitures.

These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in this news release. Reconciliations of our non-GAAP measures are included in the following "Supplemental Non-GAAP Reconciliations" and “Supplemental Diluted Earnings per Share Information” tables included in this news release.

We do not provide reconciliations for non-GAAP estimates on a forward-looking basis (including those contained in this news release) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of various items that have not yet occurred, are out of our control and/or cannot be reasonably predicted, and that would impact reported earnings per share and the reported tax rate, the most directly comparable forward-looking GAAP financial measures to adjusted earnings per share and the adjusted tax rate. For the same reasons, we are unable to address the probable significance of the unavailable information.

(ECL-E)

ECOLAB INC. CONSOLIDATED STATEMENTS OF INCOME (unaudited)
		First Quarter Ended
		March 31								%
(millions, except per share)			2023				2022			Change
Product and equipment sales		$	2,876.3			$	2,624.1
Service and lease sales			695.3				642.6
Net sales			3,571.6				3,266.7			9	%
Product and equipment cost of sales			1,798.3				1,695.6
Service and lease cost of sales			406.9				377.8
Cost of sales (1)			2,205.2				2,073.4			6	%
Selling, general and administrative expenses			990.3				914.7			8	%
Special (gains) and charges (1)			24.5				24.1
Operating income			351.6				254.5			38	%
Other (income) expense			(13.1	)			(18.8	)		(30	)%
Interest expense, net			74.2				53.0			40	%
Income before income taxes			290.5				220.3			32	%
Provision for income taxes			52.4				45.6			15	%
Net income including noncontrolling interest			238.1				174.7			36	%
Net income attributable to noncontrolling interest			4.7				2.8
Net income attributable to Ecolab		$	233.4			$	171.9			36	%
Earnings attributable to Ecolab per common share
Basic		$	0.82			$	0.60			37	%
Diluted		$	0.82			$	0.60			37	%
Weighted-average common shares outstanding
Basic			284.6				286.2			(1	)%
Diluted			285.9				288.1			(1	)%
(1) Cost of sales and Special (gains) and charges in the Consolidated Statement of Income above include the following:
		First Quarter Ended
		March 31
(millions)			2023				2022
Cost of sales
Restructuring activities		$	3.2			$	2.6
Acquisition and integration activities			-				27.6
COVID-19 activities, net			-				16.3
Russia/Ukraine activities			-				6.4
Subtotal (a)			3.2				52.9
Special (gains) and charges
Restructuring activities			12.6				0.8
Acquisition and integration activities			5.0				7.5
COVID-19 activities, net			-				1.5
Russia/Ukraine activities			0.3				11.6
Other			6.6				2.7
Subtotal			24.5				24.1
Total special (gains) and charges		$	27.7			$	77.0

a) Special charges of $0.8 million and $52.0 million in the first quarter of 2023 and 2022, respectively, were recorded in product and equipment cost of sales. Special charges of $2.4 million and $0.9 million in the first quarter of 2023 and 2022, respectively, were recorded in service and lease cost of sales.

ECOLAB INC. REPORTABLE SEGMENT INFORMATION (unaudited)
		First Quarter Ended March 31
		Fixed Currency Rates												Public Currency Rates
										%												%
(millions)			2023				2022			Change					2023				2022			Change
Net Sales
Global Industrial		$	1,699.3			$	1,511.4			12		%		$	1,709.4			$	1,565.7			9	%
Global Institutional & Specialty			1,126.6				991.3			14		%			1,128.8				1,009.4			12	%
Global Healthcare & Life Sciences			378.6				348.2			9		%			379.7				362.8			5	%
Other			329.3				286.8			15		%			330.0				294.0			12	%
Corporate			23.6				34.6			(32	)	%			23.7				34.8			(32	)%
Subtotal at fixed currency rates			3,557.4				3,172.3			12		%			3,571.6				3,266.7			9	%
Currency impact			14.2				94.4			*					-				-			*
Consolidated reported GAAP net sales		$	3,571.6			$	3,266.7			9		%		$	3,571.6			$	3,266.7			9	%
Operating Income (loss)
Global Industrial		$	215.6			$	179.9			20		%		$	217.7			$	191.1			14	%
Global Institutional & Specialty			125.7				108.6			16		%			125.9				110.9			14	%
Global Healthcare & Life Sciences			35.0				41.9			(16	)	%			35.2				44.3			(21	)%
Other			50.1				37.1			35		%			50.2				37.9			32	%
Corporate			(77.4	)			(129.0	)		*					(77.4	)			(129.7	)		*
Subtotal at fixed currency rates			349.0				238.5			46		%			351.6				254.5			38	%
Currency impact			2.6				16.0			*					-				-			*
Consolidated reported GAAP operating income		$	351.6			$	254.5			38		%		$	351.6			$	254.5			38	%
* Not meaningful.

As shown in the “Fixed Currency Rates” tables above, we evaluate the performance of our international operations based on fixed currency exchange rates, which eliminate the impact of exchange rate fluctuations on our international operations. Amounts shown in the “Public Currency Rates” tables above reflect amounts translated at actual public average rates of exchange prevailing during the corresponding period and are provided for informational purposes. The difference between the fixed currency exchange rates and the public currency exchange rates is reported as “Currency impact” in the “Fixed Currency Rates” tables above.

The Corporate segment includes amortization from the Nalco and Purolite transactions intangible assets. The Corporate segment also includes special (gains) and charges reported on the Consolidated Statement of Income.

ECOLAB INC. CONSOLIDATED BALANCE SHEETS (unaudited)
		March 31					December					March 31
(millions)		2023					2022					2022
Assets
Current assets
Cash and cash equivalents		$	419.4				$	598.6				$	99.4
Accounts receivable, net			2,667.8					2,698.1					2,508.2
Inventories			1,727.3					1,792.8					1,589.9
Other current assets			458.3					404.7					407.0
Total current assets			5,272.8					5,494.2					4,604.5
Property, plant and equipment, net			3,312.7					3,293.4					3,285.7
Goodwill			8,062.2					8,012.7					8,081.0
Other intangible assets, net			3,616.8					3,680.7					4,138.3
Operating lease assets			430.6					448.2					385.8
Other assets			556.4					535.1					571.9
Total assets		$	21,251.5				$	21,464.3				$	21,067.2
Liabilities and Equity
Current liabilities
Short-term debt		$	1,118.1				$	505.1				$	493.1
Accounts payable			1,469.9					1,728.2					1,423.9
Compensation and benefits			450.2					493.6					469.6
Income taxes			171.6					197.6					108.6
Other current liabilities			1,279.8					1,285.9					1,136.1
Total current liabilities			4,489.6					4,210.4					3,631.3
Long-term debt			7,521.7					8,075.3					8,267.2
Pension and postretirement benefits			665.5					670.3					874.5
Deferred income taxes			496.1					505.6					619.2
Operating lease liabilities			323.4					337.8					275.2
Other liabilities			390.2					406.3					294.7
Total liabilities			13,886.5					14,205.7					13,962.1
Equity
Common stock			365.0					364.7					364.5
Additional paid-in capital			6,626.5					6,580.2					6,501.5
Retained earnings			9,401.3					9,318.8					8,840.4
Accumulated other comprehensive loss			(1,737.2	)				(1,726.6	)				(1,563.6	)
Treasury stock			(7,311.4	)				(7,301.0	)				(7,061.2	)
Total Ecolab shareholders’ equity			7,344.2					7,236.1					7,081.6
Noncontrolling interest			20.8					22.5					23.5
Total equity			7,365.0					7,258.6					7,105.1
Total liabilities and equity		$	21,251.5				$	21,464.3				$	21,067.2

ECOLAB INC. SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited)
		First Quarter Ended
		March 31
(millions, except percent and per share)		2023				2022
Net sales
Reported GAAP net sales		$	3,571.6			$	3,266.7
Effect of foreign currency translation			(14.2	)			(94.4	)
Non-GAAP fixed currency sales			3,557.4				3,172.3
Effect of acquisitions and divestitures			(23.6	)			(34.6	)
Non-GAAP organic sales		$	3,533.8			$	3,137.7
Cost of sales
Reported GAAP cost of sales		$	2,205.2			$	2,073.4
Special (gains) and charges			3.2				52.9
Non-GAAP adjusted cost of sales		$	2,202.0			$	2,020.5
Gross profit
Reported GAAP gross profit		$	1,366.4			$	1,193.3
Special (gains) and charges			3.2				52.9
Non-GAAP adjusted gross profit		$	1,369.6			$	1,246.2
Gross margin
Reported GAAP gross margin			38.3	%			36.5	%
Non-GAAP adjusted gross margin			38.3	%			38.1	%
Operating income
Reported GAAP operating income		$	351.6			$	254.5
Effect of foreign currency translation			(2.6	)			(16.0	)
Non-GAAP fixed currency operating income			349.0				238.5
Special (gains) and charges at fixed currency rates			27.6				77.0
Non-GAAP adjusted fixed currency operating income			376.6				315.5
Effect of acquisitions and divestitures			(0.5	)			-
Non-GAAP organic operating income		$	376.1			$	315.5
Operating income margin
Reported GAAP operating income margin			9.8	%			7.8	%
Non-GAAP adjusted fixed currency operating income margin			10.6	%			9.9	%
Non-GAAP organic operating income margin			10.6	%			10.1	%

ECOLAB INC. SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited)
		First Quarter Ended
		March 31
(millions, except percent and per share)		2023				2022
Net Income attributable to Ecolab
Reported GAAP net income attributable to Ecolab		$	233.4			$	171.9
Special (gains) and charges, after tax			21.1				63.6
Discrete tax net expense (benefit)			(4.0	)			1.0
Non-GAAP adjusted net income attributable to Ecolab		$	250.5			$	236.5
Diluted EPS attributable to Ecolab
Reported GAAP diluted EPS		$	0.82			$	0.60
Special (gains) and charges, after tax			0.07				0.22
Discrete tax net expense (benefit)			(0.01	)			-
Non-GAAP adjusted diluted EPS		$	0.88			$	0.82
Provision for Income Taxes
Reported GAAP tax rate			18.0	%			20.7	%
Special gains and charges			0.5				(0.9	)
Discrete tax items			1.3				(0.3	)
Non-GAAP adjusted tax rate			19.8	%			19.5	%

 

ECOLAB INC. SUPPLEMENTAL NON-GAAP RECONCILIATIONS (unaudited)
		First Quarter Ended March 31
		2023												2022
(millions)		Fixed Currency				Impact of Acquisitions and Divestitures				Organic				Fixed Currency				Impact of Acquisitions and Divestitures				Organic
Net Sales
Global Industrial		$	1,699.3			$	-			$	1,699.3			$	1,511.4			$	-			$	1,511.4
Global Institutional & Specialty			1,126.6				-				1,126.6				991.3				-				991.3
Global Healthcare & Life Sciences			378.6				-				378.6				348.2				-				348.2
Other			329.3				-				329.3				286.8				-				286.8
Corporate			23.6				(23.6	)			-				34.6				(34.6	)			-
Subtotal at fixed currency rates			3,557.4				(23.6	)			3,533.8				3,172.3				(34.6	)			3,137.7
Currency impact			14.2												94.4
Consolidated reported GAAP net sales		$	3,571.6											$	3,266.7
Operating Income (loss)
Global Industrial		$	215.6			$	-			$	215.6			$	179.9			$	-			$	179.9
Global Institutional & Specialty			125.7				-				125.7				108.6				-				108.6
Global Healthcare & Life Sciences			35.0				-				35.0				41.9				-				41.9
Other			50.1				-				50.1				37.1				-				37.1
Corporate			(49.8	)			(0.5	)			(50.3	)			(52.0	)			-				(52.0	)
Subtotal at fixed currency rates			376.6				(0.5	)			376.1				315.5				-				315.5
Special (gains) and charges at fixed currency rates			27.6												77.0
Reported OI at fixed currency rates			349.0												238.5
Currency impact			2.6												16.0
Consolidated reported GAAP operating income		$	351.6											$	254.5

ECOLAB INC.

SUPPLEMENTAL DILUTED EARNINGS PER SHARE INFORMATION

(unaudited)

The table below provides a reconciliation of diluted earnings per share, as reported, to the non-GAAP measure of adjusted diluted earnings per share.

		First			Second			Six			Third				Nine				Fourth
		Quarter			Quarter			Months			Quarter				Months				Quarter				Year
		Ended			Ended			Ended			Ended				Ended				Ended				Ended
		Mar. 31			June 30			June 30			Sept. 30				Sept. 30				Dec. 31				Dec. 31
			2022			2022			2022			2022				2022				2022				2022
Diluted earnings per share, as reported (U.S. GAAP)		$	0.60		$	1.08		$	1.67		$	1.21			$	2.88			$	0.93			$	3.81
Adjustments:
Special (gains) and charges (1)			0.22			0.01			0.23			0.14				0.37				0.35				0.72
Discrete tax expense (benefits) (2)			0.00			0.01			0.02			(0.05	)			(0.03	)			(0.01	)			(0.04	)
Adjusted diluted earnings per share (Non-GAAP)		$	0.82		$	1.10		$	1.92		$	1.30			$	3.22			$	1.27			$	4.49

		First				Second			Six			Third			Nine			Fourth
		Quarter				Quarter			Months			Quarter			Months			Quarter			Year
		Ended				Ended			Ended			Ended			Ended			Ended			Ended
		Mar. 31				June 30			June 30			Sept. 30			Sept. 30			Dec. 31			Dec. 31
			2023				2023			2023			2023			2023			2023			2023
Diluted earnings per share, as reported (U.S. GAAP)		$	0.82
Adjustments:
Special (gains) and charges (3)			0.07
Discrete tax expense (benefits) (4)			(0.01	)
Adjusted diluted earnings per share (Non-GAAP)		$	0.88			$	0.00		$	0.00		$	0.00		$	0.00		$	0.00		$	0.00

Per share amounts do not necessarily sum due to changes in shares outstanding and rounding.

(1) Special (gains) and charges for 2022 includes charges of $63.6 million, $2.6 million, $39.6 million and $101.5 million, net of tax, in the first, second, third and fourth quarters, respectively. Charges were primarily related to acquisition and integration charges, reserves related to our operations in Russia, COVID-19 related inventory write downs and employee-related costs, restructuring charges, litigation and other charges and pension settlements.

(2) Discrete tax expenses (benefits) for 2022 includes $1.0 million, $3.7 million, ($14.2) million and ($2.3) million in the first, second, third and fourth quarters, respectively. These expenses (benefits) are primarily associated with stock compensation excess tax benefits and other discrete tax benefits.

(3) Special (gains) and charges for 2023 includes charges of $27.7 million, net of tax, in the first quarters. Charges were primarily related to restructuring charges, acquisition and integration charges and litigation and other charges.

(4) Discrete tax (benefits) for 2023 includes ($4.0) million in the first quarter. These expenses (benefits) are primarily associated with stock compensation excess tax benefits and other discrete tax benefits.

 

Source: Ecolab Inc.